Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Psoriasis Pipeline Drugs Market Report Overview
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared-up skin, itchiness, burning sensation, and swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections, and environmental conditions. The condition may be controlled by topical or systemic medications and phototherapy.
The Psoriasis pipeline market research report provides comprehensive information on the therapeutics under development for Psoriasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects.
| Key Targets | Tumor Necrosis Factor, Interleukin 23 Subunit Alpha, Interleukin 17A, Nuclear Receptor ROR Gamma, Phosphodiesterase 4, Interleukin 12 Subunit Beta, Non Receptor Tyrosine Protein Kinase TYK2, Interleukin 17, Tyrosine Protein Kinase JAK1, Interleukin 1 Receptor Like 2, Cannabinoid Receptor, and Cannabinoid Receptor 2 |
| Key Mechanisms of Action | Tumor Necrosis Factor Inhibitor, Interleukin 23 Subunit Alpha Inhibitor, Interleukin 17A Inhibitor, Nuclear Receptor ROR Gamma Antagonist, Phosphodiesterase 4 Inhibitor, Interleukin 12 Subunit Beta Inhibitor, Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor, Interleukin 17 Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Interleukin 1 Receptor Like 2 Antagonist, Cannabinoid Receptor 1 Agonist, and Cannabinoid Receptor 2 Agonist |
| Key Routes of Administration | Oral, Subcutaneous, Topical, Intravenous, Parenteral, Cutaneous, Inhalational, Intramuscular, Transdermal, Ophthalmic, Intraarterial, Intratumor, Intracardiac, Intradermal, Intralesional, Intrathecal, Intravascular, Intravenous Drip, and Nasal |
| Key Molecule Type | Small Molecule, Monoclonal Antibody, Recombinant Protein, Biologic, Fusion Protein, Synthetic Peptide, Cell Therapy, Peptide, Protein, Polysaccharide, and Subunit Vaccine |
| Major Companies | Affilogic SAS, Arcutis Biotherapeutics Inc, Bristol-Myers Squibb Co, Eli Lilly and Co, Galapagos NV, Aclaris Therapeutics Inc, Amgen Inc, and Biocon Ltd |
| Major Universities | Ludwig-Maximilians-University Munich, Hanyang University, Hokkaido University, Osaka University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Dundee, and University of Maryland School of Medicine |
Key Targets in the Psoriasis Pipeline Products Market
The key targets in the Psoriasis pipeline products market are Tumor Necrosis Factor, Interleukin 23 Subunit Alpha, Interleukin 17A, Nuclear Receptor ROR Gamma, Phosphodiesterase 4, Interleukin 12 Subunit Beta, Non-Receptor Tyrosine Protein Kinase TYK2, Interleukin 17, Tyrosine Protein Kinase JAK1, Interleukin 1 Receptor-Like 2, Cannabinoid Receptor, Cannabinoid Receptor 2, and others. Tumor Necrosis Factor has the highest number of products.
Psoriasis Pipeline Products Market Analysis by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the Psoriasis Pipeline Products Market
The key mechanisms of action in the Psoriasis pipeline products market are Tumor Necrosis Factor Inhibitor, Interleukin 23 Subunit Alpha Inhibitor, Interleukin 17A Inhibitor, Nuclear Receptor ROR Gamma Antagonist, Phosphodiesterase 4 Inhibitor, Interleukin 12 Subunit Beta Inhibitor, Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor, Interleukin 17 Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Interleukin 1 Receptor Like 2 Antagonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and others. Tumor Necrosis Factor Inhibitor leads this MoA segment.
Psoriasis Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the Psoriasis Pipeline Products Market
The key routes of administration in the psoriasis pipeline products market are oral, subcutaneous, topical, intravenous, parenteral, cutaneous, inhalational, intramuscular, transdermal, ophthalmic, intraarterial, intratumor, intracardiac, intradermal, intralesional, intrathecal, intravascular, intravenous drip, and nasal. Oral leads this RoA segment.
Psoriasis Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the Psoriasis Pipeline Products Market
The key molecule types in the Psoriasis pipeline products market are small molecule, monoclonal antibody, recombinant protein, biologic, fusion protein, synthetic peptide, cell therapy, peptide, protein, polysaccharide, subunit vaccine, and others. Small molecule leads this segment.
Psoriasis Pipeline Products Market Analysis by Molecule Types
For more molecule-type insights, download a free report sample
Key Companies in the Psoriasis Pipeline Products Market
Some of the major companies in the Psoriasis pipeline drugs market are Affilogic SAS, Arcutis Biotherapeutics Inc, Bristol-Myers Squibb Co, Eli Lilly and Co, Galapagos NV, Aclaris Therapeutics Inc, Amgen Inc, Biocon Ltd, and others. Affilogic SAS has the highest number of products in the pipeline.
Bristol-Myers Squibb Co: Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in the discovery, development, licensing and manufacturing, marketing, distribution, and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology, and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals, and government entities. BMS provides its products in the US, Europe, and Japan. The company researches to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.
Psoriasis Pipeline Products Market Analysis by Companies
For more company insights, download a free report sample
Key Universities in the Psoriasis Pipeline Products Market
Some of the key universities in the Psoriasis pipeline products market are Ludwig-Maximilians-University Munich, Hanyang University, Hokkaido University, Osaka University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Dundee, University of Maryland School of Medicine, and others. Ludwig-Maximilians-University Munich has the highest number of products in the pipeline.
Psoriasis Pipeline Products Market Analysis by Universities
For more university insights, download a free report sample
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriasis (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Psoriasis (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Psoriasis (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Psoriasis (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Psoriasis (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Psoriasis (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Psoriasis (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
AbbVie Inc
Abcentra LLC
Abclon Inc
Abivax SA
Accro BioScience (Suzhou) Co Ltd
Acelyrin Inc
Aclaris Therapeutics Inc
Actinobac Biomed Inc
Aditxt Inc
Affilogic SAS
Akaal Pharma Pty Ltd
Akeso Inc
Aldeyra Therapeutics Inc
Allergy Therapeutics Plc
AltruBio Inc
Aluda Pharmaceuticals Inc
Alumis Inc
Alvotech ehf
Amgen Inc
Amicogen Inc
Amtixbio Co Ltd
Amytrx Therapeutics Inc
AnaptysBio Inc
Annji Pharmaceutical Co Ltd
AntalGenics SL
AnTolRx Inc
Apimeds Inc
APIRx Pharmaceuticals USA LLC
Applied Biology Inc
Arbor Pharmaceuticals LLC
Arcutis Biotherapeutics Inc
Aristea Therapeutics Inc
Arrien Pharmaceuticals LLC
AstraZeneca Plc
Athenex Inc
Aurigene Discovery Technologies Ltd
Avesthagen Ltd
Avicanna Inc
Avidin Biotechnology Ltd
Avixgen Inc
Avotres Inc
Azora Therapeutics Australia Pty Ltd
Bayer AG
BCY Pharm Co Ltd
Beijing FuKangren Bio-pharm Tech Co Ltd
Beijing Guiqianjin Medical Technology Co Ltd
Beijing Northland Biotech Co Ltd
Beijing Scitech-MQ Pharmaceuticals Ltd
Beijing SH biotechnology Co Ltd
Bio-Thera Solutions Ltd
BioApex sro
Biocad
Biocon Ltd
BioFactura Inc
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
BioMarck Pharmaceuticals Ltd
Biomendics LLC
Biomimetix JV LLC
Bioviz Technologies Pvt Ltd
BioXpress Therapeutics SA
Biozeus Pharmaceutical SA
BirchBioMed Inc
Boehringer Ingelheim International GmbH
Boston Pharmaceuticals Inc
Botanix Pharmaceuticals Ltd
Brickell Biotech Inc
Bristol-Myers Squibb Co
Can-Fite BioPharma Ltd
Cantargia AB
Canvax Biotech SL
Captor Therapeutics SA
Caregen Co Ltd
CellionBioMed Inc
Cellivery Therapeutics Inc
Cellix Bio Pvt Ltd
Celltrion Inc
Celon Pharma SA
Centrymed Pharmaceutical Inc
Changzhou Hengbang Pharmaceutical Co Ltd
CheckPoint Immunology Inc
ChemoCentryx Inc
Chengdu Jinrui Foundation Biotechnology Co Ltd
Chiesi Farmaceutici SpA
Clonz Biotech Pvt Ltd
Coegin Pharma AS
Compugen Ltd
Crescita Therapeutics Inc
CSL Ltd
CSPC Pharmaceutical Group Ltd
Curapel Ltd
Cythera Inc
Cytodyn Inc
Daewoong Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Dalriada Therapeutics Inc
Deka Biosciences Inc
DelArrivo Inc
Denali Therapeutics Inc
Derm-Biome Pharmaceuticals Inc
Dermaliq Therapeutics Inc
Dermata Therapeutics Inc
Dermavant Sciences Inc
DICE Therapeutics Inc
DM Bio Ltd
DNX Biopharmaceuticals Inc
Dong-A ST Co Ltd
Dr. August Wolff GmbH & Co KG Arzneimittel
Dyve Biosciences Inc
Eden Biologics Inc
Egret Therapeutics Inc
Eli Lilly and Co
ELORAC Inc
Enitiate Biopharmaceuticals (Hangzhou) Co Ltd
Enzychem Lifesciences Corp
Eolo Pharma
Erganeo
Escalier Biosciences BV
Eternity Bioscience Inc
Evelo Biosciences Inc
Evommune Inc
Exicure Inc
Exogenus Therapeutics SA
Formycon AG
FunPep Co Ltd
Galapagos NV
Galectin Therapeutics Inc
Generium
GeneScience Pharmaceuticals Co Ltd
Genesen Co Ltd
Genor BioPharma Co Ltd
Genosco Inc
Genrix (Shanghai) Biopharmaceutical Co Ltd
GlycoMar Ltd
Green Cross LabCell Corp
GSK plc
Guangdong Yinzhu Pharmaceutical Technology Co Ltd
Haisco Pharmaceutical Group Co Ltd
HK inno.N Corp
HLK Pharmacin LLC
Hoth Therapeutics Inc
Huabo Biopharm (Shanghai) Co Ltd
Hualan Biological Engineering Inc
Huaxia Source Cell Engineering Group Co Ltd
ILC Therapeutics Ltd
Iltoo Pharma
IMD-Pharma SAS
IMGENEX India Pvt Ltd
Immune Pharmaceuticals Inc
ImmuneMed Inc
Immungenetics AG
Immunic Inc
ImmunoBiome Inc
Immunwork Inc
Impetis Biosciences Ltd
Inflection Biosciences Ltd
Inmagene Biopharmaceuticals Ltd
InnoCare Pharma Ltd
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Instituto Biomar SA
Io Therapeutics Inc
Istesso Ltd
J2H Biotech
Japan Tobacco Inc
Jiangsu Carephar Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
JiangSu Qyuns Therapeutics Co Ltd
Johnson & Johnson
JS InnoPharm (Shanghai) Ltd
Jubilant Therapeutics Inc
Kangpu Biopharmaceuticals Ltd
Kine Sciences
Kiniksa Pharmaceuticals Ltd
KoBioLabs Inc
Krystal Biotech Inc
Kymab Ltd
Landos Biopharma Inc
Lead Pharma Holding BV
Leo Pharma AS
Link Health Group
Lipidor AB
Livzon Pharmaceutical Group Co Ltd
Luye Pharma Group Ltd
Lynk Pharmaceutical Hangzhou Co Ltd
Mabpharm Ltd
Machavert Pharmaceuticals LLC
Maruho Co Ltd
MC2 Therapeutics AS
medac GmbH
Medipure Pharmaceuticals Inc
Meiji Seika Pharma Co Ltd
Metrion Biosciences Ltd
MetrioPharm AG
Mical Pharmaceuticals LLC
Midatech Pharma Plc
MoonLake Immunotherapeutics
Mycenax Biotech Inc
Nanjing Aimeifei Biomedical Technology Co Ltd
Nanjing Ruijie Pharmaceutical Technology Co Ltd
NanoPharmaceuticals LLC
Nektar Therapeutics
Nepsone ehf
NeuClone Pty Ltd
Nimbus Therapeutics LLC
NKGen Biotech Inc
North China Pharmaceutical Group New Drug Research and Development Co Ltd
NovaLead Pharma Pvt Ltd
NovaRock Biotherapeutics Inc
Numab Therapeutics AG
Olys Pharma
OncoSynergy Inc
One World Cannabis Ltd
Ono Pharmaceutical Co Ltd
Orgenesis Inc
Orphagen Pharmaceuticals Inc
OSE Immunotherapeutics SA
Outlook Therapeutics Inc
Palo BioFarma SL
Panaxia Pharmaceutical Industries Ltd
Par'Immune SAS
Paracrine Therapeutics Pte Ltd
PB Immune Therapeutics Co Ltd
Pfizer Inc
Phaim Pharma Ltd
Pharmapraxis
PIQUR Therapeutics AG
Polpharma Biologics SA
PRCL Research Inc
Precigen ActoBio Inc
Principia Biopharma Inc
Progenra Inc
Protagonist Therapeutics Inc
Protein Foundry LLC
Protheragen Inc
ProTransit Nanotherapy LLC
Provectus Biopharmaceuticals Inc
Pyramid Biosciences Inc
Rebus Holdings Inc
Regeneus Ltd
Regranion LLC
Reliance Life Sciences Pvt Ltd
Revive Therapeutics Ltd
Rigel Pharmaceuticals Inc
Samsung Bioepis Co Ltd
Sanofi
Sareum Holdings Plc
SBI Biotech Co Ltd
Servatus Ltd
SFA Therapeutics Inc
Shandong Danhong Pharmaceutical Co Ltd
Shanghai Celgen Bio-Pharmaceutical Co Ltd
Shanghai Huiqi Biomedical Technology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Shulov Innovative Science Ltd
Siam Bioscience Co Ltd
Sienna Biopharmaceuticals Inc
Simcere Pharmaceutical Group Ltd
Singh Biotechnology LLC
SinoCelltech Group Ltd
siRNAgen Therapeutics Corp
Sol-Gel Technologies Ltd
Soligenix Inc
Sublimity Therapeutics HoldCo Ltd
Sun Pharma Advanced Research Company Ltd
Sun Pharmaceutical Industries Ltd
Sunny BioDiscovery Inc
Suzhou Connect Biopharmaceuticals Ltd
Suzhou Pharmavan Cancer Research Center Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Syntrix Pharmaceuticals
Technoderma Medicines Inc
Temisis Therapeutics
Tianjin Ever Union Biotechnology Co Ltd
Tianjin Hemay Pharmaceutical Co Ltd
TLL Pharmaceutical LLC
Tonghua Dongbao Pharmaceutical Co Ltd
UCB SA
Union Therapeutics AS
Usynova Pharmaceuticals Ltd
Valin Technologies Ltd
Ventyx Biosciences Inc
Vidasym Inc
Visionary Pharmaceuticals Inc
Viva Vision Biotech
vTv Therapeutics Inc
Welichem Biotech Inc
Wellstat Therapeutics Corp
WntResearch AB
Wuhan Institute of Biological Products Co Ltd
Wuhan LL Science and Technology Development Co Ltd
YIRUI Pharmaceutical Technology Co Ltd
Zai Lab Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Psoriasis products market?
The key targets in the Psoriasis pipeline products market are Tumor Necrosis Factor, Interleukin 23 Subunit Alpha, Interleukin 17A, Nuclear Receptor ROR Gamma, Phosphodiesterase 4, Interleukin 12 Subunit Beta, Non Receptor Tyrosine Protein Kinase TYK2, Interleukin 17, Tyrosine Protein Kinase JAK1, Interleukin 1 Receptor Like 2, Cannabinoid Receptor , Cannabinoid Receptor 2, and others.
-
What are the key mechanisms of action in the Psoriasis pipeline products market?
The key mechanisms of action in the Psoriasis pipeline products market are Tumor Necrosis Factor Inhibitor, Interleukin 23 Subunit Alpha Inhibitor, Interleukin 17A Inhibitor, Nuclear Receptor ROR Gamma Antagonist, Phosphodiesterase 4 Inhibitor, Interleukin 12 Subunit Beta Inhibitor, Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor, Interleukin 17 Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Interleukin 1 Receptor Like 2 Antagonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and others.
-
What are the key routes of administration in the Psoriasis pipeline products market?
The key routes of administration in the Psoriasis pipeline products market are oral, subcutaneous, topical, intravenous, parenteral, cutaneous, inhalational, intramuscular, transdermal, ophthalmic, intraarterial, intratumor, intracardiac, intradermal, intralesional, intrathecal, intravascular, intravenous drip, and nasal.
-
What are the key molecule types in the Psoriasis pipeline products market?
The key molecule types in the Psoriasis pipeline products market are small molecule, monoclonal antibody, recombinant protein, biologic, fusion protein, synthetic peptide, cell therapy, peptide, protein, polysaccharide, subunit vaccine, and others.
-
Which are the major companies in the Psoriasis pipeline products market?
Some of the major companies in the Psoriasis pipeline products market are Affilogic SAS, Arcutis Biotherapeutics Inc, Bristol-Myers Squibb Co, Eli Lilly and Co, Galapagos NV, Aclaris Therapeutics Inc, Amgen Inc, Biocon Ltd, and others.
-
Which are the major universities in the Psoriasis pipeline products market?
Some of the major universities in the Psoriasis pipeline products market are Ludwig-Maximilians-University Munich, Hanyang University, Hokkaido University, Osaka University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Dundee, University of Maryland School of Medicine, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Immunology reports